NYSE$AHR

American Healthcare REIT Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

American Healthcare REIT Inc's Q1 2024 results were announced, highlighting strong performance in RIDEA-operated assets and strategic portfolio adjustments.

American Healthcare REIT reported a net loss of $(0.04) per share, but achieved a 13.0% growth in total portfolio Same-Store NOI, driven by strong performance in senior housing operating properties and integrated senior health campuses. The company also completed a public offering and paid down a significant amount of debt, improving its financial flexibility.

  • Reported GAAP net loss attributable to common stockholders of $(0.04) per basic and diluted share.
  • Reported Normalized Funds from Operations attributable to common stockholders (“NFFO”) of $0.30 per basic and diluted share.
  • Achieved 7.1% total portfolio Same-Store (“SS”) revenue growth.
  • Achieved total portfolio Same-Store Net Operating Income (“NOI”) growth of 13.0%.

Headline financials

Total Revenue

$500M

Previous: $409M+22.2%
EPS

-$0.04

Previous: -$0.39+89.7%
Capital Expenditures

-$352K

Previous: -$11.7M+97.0%
Free Cash Flow

-$4.24M

Previous: -$37.6M+88.7%
Net Income

-$3.89M

Previous: -$25.9M+85.0%
Operating Income

$82.2M

Previous: $66.9M+22.9%
Gross Profit

$95.9M

Previous: $38.5M+149.2%
Cash & Equivalents

$77M

Previous: $41.3M+86.3%
Total Assets

$4.7B

Previous: $4.75B-0.9%
Stock-Based Comp

$1.94M

Previous: $1.07M+80.5%

Revenue & EPS history

American Healthcare REIT Inc · Revenue · Quarterly

$500M

Q1 2024+22.2%vs Q1 2023
Beat estimate in 3 of 8 quarters(38%)
ActualEstimate

Revenue by segment

American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024

  • ISHC
    $423M
  • SHOP
    $73.5M
  • Outpatient Medical
    $33.3M
  • Triple-Net Leased
    $12.6M

Forward guidance

The company's full year 2024 guidance, originally announced on March 21, 2024, remains unchanged.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 11 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+1.8%

Avg return

Earnings day

+2.2%

Avg return

5 days after

+3.9%

Avg return

30 days after

64%

7 / 11 earnings

Positive

+8.3%

Q1 2025

Best reaction

-2.1%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.3%+4.1%-4.2%
Q4 2025-2.1%-2.5%-11.4%
Q3 2025+3.0%-0.1%+4.6%
Q2 2025+1.3%+2.0%+7.2%
Q1 2025+8.3%+6.1%+10.2%
Q4 2024-1.3%+0.7%+0.8%
Q3 2024+1.2%+2.7%+7.1%
Q2 2024+3.3%+3.6%+35.1%
Q1 2024-0.1%+3.5%+6.2%
Q2 2023+2.8%+1.3%-6.8%
Q4 2023-0.8%+3.2%-5.9%
Q3 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Q1 2022
Q4 2021
Q3 2021
Q2 2021
Q1 2021
Q4 2020
Q3 2020
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q3 2018
Q2 2018
Q1 2018
Q3 2017
Q2 2017
Q1 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro